N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility

@article{Dodd2008NacetylcysteineFA,
  title={N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility},
  author={Seetal Dodd and Olivia M. Dean and David L. Copolov and Gin S. Malhi and Michael Berk},
  journal={Expert Opinion on Biological Therapy},
  year={2008},
  volume={8},
  pages={1955 - 1962}
}
  • S. Dodd, O. Dean, M. Berk
  • Published 6 November 2008
  • Medicine, Psychology
  • Expert Opinion on Biological Therapy
Background: Glutathione is an endogenous antioxidant and has a ubiquitous role in many of the body's defences. Treatment with N-acetylcysteine (NAC) has been shown to increase levels of glutathione. NAC has been proposed as a treatment for several illnesses. Objectives: The efficacy and tolerability of NAC was examined across a range of conditions to evaluate the evidence supporting the use of NAC for each indication. Methods: A literature search was conducted using PubMed. Information was also… 
N-Acetylcysteine amide: a derivative to fulfill the promises of N-Acetylcysteine
TLDR
An amide derivative N-Acetylcysteine amide (NACA) has been synthesized to improve the lipophilicity, membrane permeability, and antioxidant property of NAC and its derivatives.
The promise of N-acetylcysteine in neuropsychiatry.
The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial.
Potential Role of N-Acetylcysteine in the Management of Substance Use Disorders
TLDR
This review will focus specifically on N-acetylcysteine (NAC), a safe and well-tolerated glutamatergic agent, as a promising potential pharmacotherapy for the treatment of SUDs across several substances of abuse.
N-acetylcysteine in addiction management: current knowledge and future perspectives
TLDR
The role of N-acetylcysteine in the addiction, such as cannabis abuse, methamphetamine abuse, cocaine addiction, nicotine dependency, and gambling is reviewed.
Benefit of N-Acetylcysteine in Postoperative Hepatic Dysfunction: Case Report and Review of Literature
TLDR
A case of postoperative hepatic dysfunction of multifactorial etiology in a patient with therapeutic acetaminophen levels, where hepatic function improved considerably following administration of intravenous NAC is presented.
N-Acetylcysteine in Postoperative Hepatic Dysfunction: Case Report and Review of Literature
TLDR
A case of postoperative hepatic dysfunction of multifactorial etiology in a patient with therapeutic acetaminophen levels, where hepatic function improved considerably following administration of intravenous NAC is presented, suggesting that NAC should be considered for treatment of acute liver dysfunction in the postoperative setting, even in the absence of elevated acetamophen levels.
A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania
TLDR
Although the sample size was small, these results indicated within-group efficacy for this glutathione precursor as compared to placebo, and future trials specifically designed to demonstrate the efficacy of NAC in mania are needed.
...
...

References

SHOWING 1-10 OF 80 REFERENCES
N-Acetylcysteine--a safe antidote for cysteine/glutathione deficiency.
N-acetylcysteine -- passe-partout or much ado about nothing?
  • M. Aitio
  • Medicine
    British journal of clinical pharmacology
  • 2006
TLDR
In intensive care NAC has mostly been a disappointment but recently it has 'given promises' in surgery with cardiopulmonary bypass and even meta-analyses disagree on its efficacy.
Clinical Pharmacokinetics of N-Acetylcysteine
TLDR
It appears that the administration of charcoal may interfere with drug absorption, with up to 96% of the drug adsorbed on to the charcoal, and drug interactions of clinical significance have been observed with paracetamol, glutathione and anticancer agents.
Pharmacokinetic and pharmacodynamic studies of N-acetylcysteine, a potential chemopreventive agent during a phase I trial.
  • L. Pendyala, P. Creaven
  • Medicine
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • 1995
TLDR
The goals of the study were to define the highest nontoxic dose, the toxicity profile, and the pharmacokinetics and pharmacodynamics of N-acetylcysteine, a potential chemopreventive agent, given daily p.o.s. for 6 months.
N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial
Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjects
TLDR
Therapeutic doses of N-acetylcysteine cause abnormal haemostatic activity, and this should be taken into account when using haemOSTatic function tests as an indicator of hepatic injury.
Oxidative Damage and Schizophrenia: The Potential Benefit by Atypical Antipsychotics
TLDR
There was a significant increase in serum SOD, serum MDA and a decrease in plasma ascorbic acid in schizophrenic patients as compared to control subjects, and the trend altered significantly after the treatment with atypical antipsychotics.
N-Acetylcysteine as a Potential Antidote and Biomonitoring Agent of Methylmercury Exposure
TLDR
In pregnant rats, NAC markedly reduced the body burden of MeHg, particularly in target tissues such as brain, placenta, and fetus, and NAC should be evaluated as a potential antidote and biomonitoring agent in humans.
High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis.
TLDR
High-dose oral N-acetylcysteine has the potential to counter the intertwined redox and inflammatory imbalances in CF.
An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: A pilot study
...
...